Published in Pharma and Healthcare category by MBA Skool Team
Mylan Pharmaceuticals is one of the leading brands in the pharma and healthcare sector. Mylan Pharmaceuticals SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Mylan Pharmaceuticals:
Mylan has strong generic portfolio with more than 1000 individual products
It has strong global presence in more than 150 countries
Their major strength is vertically integrated supply chain
Mylan has acquired generic business of Merck & Matrix pharmaceuticals which is largest generic Manufacturer in India
It has more than 15,000 well trained employees
Above are the strengths in the SWOT Analysis of Mylan Pharmaceuticals. The strengths of Mylan Pharmaceuticals looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Mylan Pharmaceuticals Weaknesses
Alleged litigations have sometimes impacted its public image
Very limited portion of its revenue comes from foreign business
These were the weaknesses in the Mylan Pharmaceuticals SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Mylan Pharmaceuticals Opportunities
Expiry of patent on Lipitor has open new business opportunities
Increasing awareness about healthcare
Increasing prevalence of chronic diseases such as cancer
Above we covered the opportunities in Mylan Pharmaceuticals SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Mylan Pharmaceuticals Threats
Global economic slowdown
More stringent patent protection laws
The threats in the SWOT Analysis of Mylan Pharmaceuticals are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Mylan Pharmaceuticals SWOT analysis.
Continue reading more about the brand/company.
About Mylan Pharmaceuticals
The table below gives the brand overview along with its target market, segmentation, positioning & USP
It is third largest generics manufacturing company in U.S
Mylan Pharmaceuticals STP
API, nebulized respiratory or severe allergy medications & anti retroviral drugs
Healthcare professionals & doctors providing solutions in ART, respiratory diseases
Mylan is the company, which innovates to satisfy the unmet medical need & aims to provide 7 billion people of world medical solutions.
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Mylan Pharmaceuticals. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute